 |
 |
HK J Paediatr (New Series)
Vol 29. No. 2,
2024
|
|
HK J Paediatr (New Series) 2024;29:69-73
Original Article
Mitochondrial m.1555A>G Mutation, Prevalence and Clinical Features in a Hong Kong Chinese Cohort
LT Leung, MMK Lee, SSW Cheng, HM Luk, IFM Lo Clinical Genetics Service Unit, Hong Kong Children's Hospital, 1 Shing Cheong Road, Kowloon Bay, Kowloon, Hong Kong SAR, China LT Leung (梁礪婷) MRCPCH(UK) MMK Lee (李文傑) BSc(Biomedical Science)(CUHK) student SZW Cheng (鄭斯穎) FHKAM(Paed) HM Luk (陸浩明) FHKAM(Paed) IFM Lo (盧輝文) FHKAM(Paed) Correspondence to: Dr HM Luk Email: lukhm@ha.org.hk Received August 11, 2023
Abstract Mitochondrial m.1555A>G mutation in the 12S rRNA gene (MIM* 561000) is associated with maternally-inherited aminoglycoside–induced hearing loss and non–syndromic deafness. Herein we report 14 Hong Kong Chinese families with m.1555A>G mutation. Individuals in hese families had variable hearing thresholds ranging from normal to profound hearing impairment with variable age of onset, which were consistent with typical findings of incomplete penetrance and variable expressivity for m.1555A>G mutation in previous studies overseas and among the Chinese population. No patient could recall previous history of exposure to aminoglycoside or antibiotic before onset of hearing impairment. It is hoped that through this study, the awareness of m.1555A>G mutation related hearing impairment could be raised among healthcare professionals and the general public so that carriers' exposure to potentially ototoxic drugs could be avoided. Keyword : Aminoglycoside–induced ototoxicity; Hearing impairment; Hong Kong Chinese; Mitochondrial m.1555A>G
|
|
 |